Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Swedish Prostate Cancer Initiative for Novel Treatment Regimens - Real, Implementation of Precision Medicine in High-risk Prostate Cancer

NCT06687421 is registered in ClinicalTrials.gov with Andreas Josefsson as lead sponsor.

NCT NCT06687421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Swedish Prostate Cancer Initiative for Novel Treatment Regimens - Real, Implementation of Precision Medicine in High-risk Prostate Cancer
Lead sponsor
Andreas Josefsson
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2024
Completion date
December 31, 2054
Enrollment
5,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer